Inspire Veterinary Partners, Inc. (IVPR) Stock Price & Analysis
Inspire Veterinary Partners, Inc. (IVPR) fell 50.00% to USD 0 as of July 25, 2026 at 22:15 UTC, according to Nexqual real-time market data.
IVPR last closed at USD 0; the session ranged USD 0–0 on volume of 200 shares. Market capitalization is $11,898, with a 52-week range of USD 0–1.34 (PNK). Source: Nexqual, July 25, 2026 at 22:15 UTC.
Key Statistics (as of July 25, 2026 at 22:15 UTC)
| Price | USD 0 |
|---|---|
| Change | ▼ 50.00% (down) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 1.34 |
| Volume | 200 shares |
| Market Cap | $11,898 |
| Exchange | PNK |
Technical Analysis (IVPR)
Nexqual's technical model rates IVPR "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of July 25, 2026 at 22:15 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 27.16 (oversold) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (IVPR)
Wall Street analysts rate IVPR "None", per Nexqual as of July 25, 2026 at 22:15 UTC.
| Consensus Rating | None |
|---|
Earnings (IVPR)
Source: Nexqual, July 25, 2026 at 22:15 UTC.
Financials & Fundamentals (IVPR)
| Total Revenue | $15.56M |
|---|---|
| Revenue Growth (YoY) | +6.60% |
| Gross Margin | +19.36% |
| Operating Margin | -45.58% |
| Profit Margin | -76.75% |
| ROE | -331.80% |
| Debt / Equity | 410.61 |
| Current Ratio | 0.39 |
| Total Cash | $2.91M |
| Total Debt | $17.12M |
| Free Cash Flow | $-129,976 |
Source: Nexqual, July 25, 2026 at 22:15 UTC.
Financial Health Score (IVPR)
Nexqual rates Inspire Veterinary Partners, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 22:15 UTC.
| Growth | Solid — Revenue +7% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Critical — $3M cash vs $17M debt |
| Cash Flow | Weak — FCF negative: -$130K, burning cash |
| Efficiency | Critical — ROE -332%, ROA -24.0% |
Ownership (IVPR)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.06% |
| Shares Outstanding | 118.95M |
| Float | 6.69M |
| Short % of Float | +1.63% |
Source: Nexqual, July 25, 2026 at 22:15 UTC.
Leadership (IVPR)
Inspire Veterinary Partners, Inc. is led by Kimball Carr (age 54), Chairman, CEO & President, per Nexqual as of July 25, 2026 at 22:15 UTC.
| Chairman, CEO & President | Kimball Carr (age 54) |
|---|---|
| Chief Financial Officer | Richard Paul Frank (age 56) |
| Vice President of Operations | Laura Johnson (age 42) |
| Vice President of Medical Operations | Alexandra Quarti (age 50) |
From Inspire Veterinary Partners, Inc.'s Latest SEC 10-K Filing (filed 2025-03-31)
Partnerships
- Keiser on March 7, 2024.   1     General Release   On March 6, 2024, Inspire entered into a general release agreement with Kenneth Seth Lundquist, DVM, Charles "Chuck" Keiser, DVM, and Don I.
- A supplement to the prospectus contained in the Registration Statement filed with the Commission on October 22, 2024.   Spartan Capital Securities, LLC acted as the sole placement agent for the offering and received a fee of 8% of the gross proceeds, reimbursement of $25,000 in non-accountable expenses, and up to $75,000 in legal fees and out-of-pocket expenses, pursuant to a letter of engagement between the Company and Spartan.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ZAPPF | Zapp Electric Vehicles Group Li | USD 0 | ▼ 50% |
| CTNT | Cheetah Net Supply Chain Servic | USD 1.73 | ▲ 11.61% |
| LRHC | La Rosa Holdings Corp. | USD 0.97 | ▲ 5.87% |
| ATPC | Agape ATP Corporation | USD 2.46 | ▼ 2.77% |
| BDRX | Biodexa Pharmaceuticals plc | USD 1.65 | ▼ 3.51% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 22:15 UTC. This page is informational and not investment advice.